Trastuzumab-Resistant HER2 Positive Breast Cancer Reversed By Treatment with INB03
11 déc. 2018 08h30 HE
|
INmune Bio, Inc.
Study Results Presented at San Antonio Breast Cancer Symposium 2018 LA JOLLA, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- INmune Bio, Inc., an immunotherapy company developing treatments to...